XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
IPO [Member]
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ 7,451   $ 1 $ 0   $ 50,096 $ (3) $ (42,643)
Beginning balance (in shares) at Dec. 31, 2020     66,155,340 0 9,896,666      
Shares issued during the period for vested restricted stock awards, Shares     1,169,607          
Repurchase of treasury stock     (148,440)   148,440      
Issuance of common stock upon exercise of stock options 39         39    
Issuance of common stock upon exercise of stock options (in shares)     152,902          
Stock-based compensation 449         449    
Net Income (loss) (7,442)             (7,442)
Other comprehensive income (loss) (1)           (1)  
Ending balance at Mar. 31, 2021 496   $ 1 $ 0   50,584 (4) (50,085)
Ending balance (in shares) at Mar. 31, 2021     67,329,409 0 10,045,106      
Beginning balance at Dec. 31, 2020 7,451   $ 1 $ 0   50,096 (3) (42,643)
Beginning balance (in shares) at Dec. 31, 2020     66,155,340 0 9,896,666      
Net Income (loss) (59,792)              
Ending balance at Jun. 30, 2021 180,772   $ 8 $ 0 $ 0 283,196 3 (102,435)
Ending balance (in shares) at Jun. 30, 2021     84,301,595 0 10,762,566      
Beginning balance at Mar. 31, 2021 496   $ 1 $ 0   50,584 (4) (50,085)
Beginning balance (in shares) at Mar. 31, 2021     67,329,409 0 10,045,106      
Shares issued during the period for vested restricted stock awards, Shares     2,244,242          
Repurchase of treasury stock     (717,460)   717,460      
Issuance of common stock upon exercise of stock options 11         11    
Issuance of common stock upon exercise of stock options (in shares)     60,788          
Repurchase and retirement of common stock (54,155)   $ (1)     (54,154)    
Repurchase and retirement of common stock (shares)     (4,455,384)          
Impact of Stock Split     $ 6     (6)    
Deferred offering costs (7,093)         (7,093)    
Issuance of common stock 241,155   $ 2     241,153    
Issuance of common stock (in shares)     19,840,000          
Stock-based compensation 52,701         52,701    
Net Income (loss) (52,350)             (52,350)
Other comprehensive income (loss) 7           7  
Ending balance at Jun. 30, 2021 180,772   $ 8 $ 0 $ 0 283,196 3 (102,435)
Ending balance (in shares) at Jun. 30, 2021     84,301,595 0 10,762,566      
Beginning balance at Dec. 31, 2021 142,866   $ 9 $ 0   292,082 7 (149,232)
Beginning balance (in shares) at Dec. 31, 2021     92,619,641 0 10,762,566      
Shares issued during the period for vested restricted stock awards, Value     $ 1     (1)    
Shares issued during the period for vested restricted stock awards, Shares     5,311,326          
Issuance of common stock upon exercise of stock options 428         428    
Issuance of common stock upon exercise of stock options (in shares)     1,793,876          
Stock-based compensation 4,610         4,610    
Net Income (loss) (27,793)             (27,793)
Other comprehensive income (loss) 57           57  
Ending balance at Mar. 31, 2022 120,168   $ 10 $ 0   297,119 64 (177,025)
Ending balance (in shares) at Mar. 31, 2022     99,724,843 0 10,762,566      
Beginning balance at Dec. 31, 2021 142,866   $ 9 $ 0   292,082 7 (149,232)
Beginning balance (in shares) at Dec. 31, 2021     92,619,641 0 10,762,566      
Issuance of common stock (in shares)   4,455,384            
Net Income (loss) (53,476)              
Ending balance at Jun. 30, 2022 99,999   $ 10 $ 0 $ 0 302,573 124 (202,708)
Ending balance (in shares) at Jun. 30, 2022     101,720,174 0 10,762,566      
Beginning balance at Mar. 31, 2022 120,168   $ 10 $ 0   297,119 64 (177,025)
Beginning balance (in shares) at Mar. 31, 2022     99,724,843 0 10,762,566      
Shares issued during the period for vested restricted stock awards, Shares     729,106          
Issuance of common stock upon exercise of stock options 86         86    
Issuance of common stock upon exercise of stock options (in shares)     266,225          
Shares issued for HX Tracker acquisition, Shares     1,000,000          
Shares issued for HX Tracker acquisition, Amount 4,370         4,370    
Stock-based compensation 998         998    
Net Income (loss) (25,683)             (25,683)
Other comprehensive income (loss) 60           60  
Ending balance at Jun. 30, 2022 $ 99,999   $ 10 $ 0 $ 0 $ 302,573 $ 124 $ (202,708)
Ending balance (in shares) at Jun. 30, 2022     101,720,174 0 10,762,566